Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.010
+0.080 (2.73%)
Mar 31, 2025, 1:23 PM EDT - Market open

Atea Pharmaceuticals Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Atea Pharmaceuticals stock has a target of 6.88, which predicts an increase of 128.57% from the current stock price of 3.01.

Analyst Consensus: Hold
Target Low Average Median High
Price $6.88 $6.88 $6.88 $6.88
Change +128.57% +128.57% +128.57% +128.57%
* Price targets were last updated on Aug 13, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for Atea Pharmaceuticals is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 000000
Buy 000000
Hold 111111
Sell 000000
Strong Sell 000000
Total 111111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Morgan Stanley
Morgan Stanley
Hold
Upgrades
$2$6.88
Hold Upgrades $2$6.88 +128.57% Aug 13, 2024
JP Morgan
JP Morgan
Sell
Downgrades
n/a
Sell Downgrades n/a n/a Aug 10, 2023
JP Morgan
JP Morgan
Hold
Maintains
$12$8
Hold Maintains $12$8 +165.78% Mar 16, 2023
SVB Leerink
SVB Leerink
Hold
Maintains
$8$6
Hold Maintains $8$6 +99.34% Jan 27, 2023
Morgan Stanley
Morgan Stanley
Sell
Maintains
$7$4
Sell Maintains $7$4 +32.89% Jan 24, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
305.41M
EPS This Year
-1.73
from -2.00
EPS Next Year
-1.72
from -1.73
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
48.63M351.37M----305.41M-
Revenue Growth
-622.49%------
EPS
-0.511.37-1.39-1.63-2.00-1.73-1.72-1.44
EPS Growth
--------
Forward PE
--------
No. Analysts -----554
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026
High n/a 925.3M
Avg n/a 305.4M
Low n/a n/a

Revenue Growth

Revenue Growth 20252026
High - -
Avg - -
Low - -

EPS Forecast

EPS 202520262027
High -1.72 -1.67 -1.28
Avg -1.73 -1.72 -1.44
Low -1.72 -1.74 -1.57

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.